These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4105330)

  • 1. Effects of magnesium on parathyroid hormone secretion during chronic haemodialysis.
    Pletka P; Bernstein DS; Hampers CL; Merrill JP; Sherwood LM
    Lancet; 1971 Aug; 2(7722):462-3. PubMed ID: 4105330
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between magnesium and secondary hyperparathyroidism during long-term hemodialysis.
    Pletka P; Bernstein DS; Hampers CL; Merrill JP; Sherwood LM
    Metabolism; 1974 Jul; 23(7):619-30. PubMed ID: 4600477
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypomagnesemia. Suppression of secondary hyperparathyroidism in chronic renal failure.
    Miller PD; Krebs RA; Neal BJ; McIntyre DO
    JAMA; 1979 Feb; 241(7):722-3. PubMed ID: 762831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of magnesium on parathyroid hormone secretion during chronic haemodialysis.
    Stewart WK; Fleming LW
    Lancet; 1971 Oct; 2(7729):879-80. PubMed ID: 4106904
    [No Abstract]   [Full Text] [Related]  

  • 5. When is Vitamin D contraindicated in dialysis patients?
    Khosla N; Sprague SM
    Semin Dial; 2009; 22(3):249-51. PubMed ID: 19573002
    [No Abstract]   [Full Text] [Related]  

  • 6. When is Vitamin D Contraindicated in Dialysis Patients?
    Goodman WG
    Semin Dial; 2009; 22(3):245-7. PubMed ID: 19573000
    [No Abstract]   [Full Text] [Related]  

  • 7. When is Vitamin D contraindicated in dialysis patients?
    Evenepoel P
    Semin Dial; 2009; 22(3):242-4. PubMed ID: 19572999
    [No Abstract]   [Full Text] [Related]  

  • 8. On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using "proportional reduction" of dietary phosphorus intake.
    Slatopolsky E; Caglar S; Gradowska L; Canterbury J; Reiss E; Bricker NS
    Kidney Int; 1972 Sep; 2(3):147-51. PubMed ID: 4669450
    [No Abstract]   [Full Text] [Related]  

  • 9. When is Vitamin D contraindicated in dialysis patients?
    Martin KJ
    Semin Dial; 2009; 22(3):247-9. PubMed ID: 19573001
    [No Abstract]   [Full Text] [Related]  

  • 10. Parathyroid hormone in patients with diabetes mellitus and end-stage renal disease on chronic haemodialysis.
    Pabico RC; Rivero AJ; McKenna BA; Freeman RB
    Proc Eur Dial Transplant Assoc; 1983; 19():221-6. PubMed ID: 6878235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of parathyroid hormone in blood from renal patients on haemodialysis.
    Walker KS; Seth J
    Ann Clin Biochem; 2000 Nov; 37 ( Pt 6)():800-1. PubMed ID: 11085628
    [No Abstract]   [Full Text] [Related]  

  • 12. [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy].
    Malluche HH; Ritz E
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):129-30. PubMed ID: 814442
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of hemodialysis on secondary hyperparathyroidism in patients with chronic renal failure.
    Johnson JW; Hattner RS; Hampers CL; Bernstein DS; Merrill JP; Sherwood LM
    Metabolism; 1972 Jan; 21(1):18-29. PubMed ID: 5008012
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D3 in patients on maintenance haemodialysis.
    Rassoul Z; Mousa D; Rehman MA; Abdalla AH; Hawas F; Popovich W; Gaisoum M; al-Sulaiman M; Al-Khader A
    Am J Nephrol; 1995; 15(6):507-11. PubMed ID: 8546173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone secretion: perturbations in chronic renal failure.
    Slatopolsky E; Lopez-Hilker S; Dusso A; Morrissey JJ; Martin KJ
    Contrib Nephrol; 1988; 64():16-24. PubMed ID: 3053034
    [No Abstract]   [Full Text] [Related]  

  • 16. The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis.
    Ohashi N; Uematsu T; Nagashima S; Kanamaru M; Togawa A; Hishida A; Uchida E; Akizawa T; Koshikawa S
    Br J Clin Pharmacol; 2004 Jun; 57(6):726-34. PubMed ID: 15151518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effect of dialysate calcium concentration and intravenous vitamin D3 on the secretion of parathyroid hormone in hemodialysis patients.
    Saha H; Pietilä K; Mustonen J; Pasternack A; Mörsky P
    Clin Nephrol; 1992 Sep; 38(3):145-8. PubMed ID: 1395167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum parathyroid hormone and trace elements (serum zinc and magnesium) in hemodialyzed chronic renal failure children.
    El Tayeb AA; Abd El-Mottaleb NA; Abdel Aziz EA
    Biol Trace Elem Res; 2009 May; 128(2):128-34. PubMed ID: 18972069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are parathyroid glands detectable by ultrasound also in normal PTH range haemodialysis patients?
    Vulpio C; Bossola M
    Nephrol Dial Transplant; 2008 Dec; 23(12):4076-7; author reply 4077. PubMed ID: 18790811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.